These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9465474)

  • 1. [The lipid patient. Case 3. Polygene hypercholesterolemia].
    Richter WO
    Fortschr Med; 1997 Dec; 115(34):38-40. PubMed ID: 9465474
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case with homozygote familial hypercholesterolemia treated with LDL apheresis and coronary bypass in adolescence period].
    Altinel E; Cetinkaya S; Kara C; Orün UA; Aydin H; Kutsal A
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):231-2. PubMed ID: 18524734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Familial hypercholesterolemia].
    Aguilar Salinas CA
    Rev Invest Clin; 2001; 53(3):254-65. PubMed ID: 11496713
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.
    Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M
    Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Hopkins PN; Toth PP; Ballantyne CM; Rader DJ;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S9-17. PubMed ID: 21600530
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for familial hypercholesterolemia: what is the most effective strategy?
    Daniels SR
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical features, diagnosis and frequency of familial hypercholesterolemia.
    Khachadurian AK
    Beitr Infusionsther; 1988; 23():26-32. PubMed ID: 2484779
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid metabolism disorders--diagnosis and therapy in general practice. 1: Hypercholesterolemia].
    Richter WO
    Fortschr Med; 1996 Apr; 114(11):133-4. PubMed ID: 8682426
    [No Abstract]   [Full Text] [Related]  

  • 10. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease.
    Castillo S; Reyes G; Tejedor D; Mozas P; Suarez Y; Lasuncion MA; Cenarro A; Civeira F; Alonso R; Mata P; Pocovi M;
    Hum Mutat; 2002 Dec; 20(6):477. PubMed ID: 12442279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
    Carmena-Ramón R; Real JT; Ascaso JF; Ordovás JM; Carmena R
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition of LDL particle discriminates between hypercholesterolaemic persons with and without symptoms of coronary heart disease.
    Van Jaarsveld H; Pool GF; Bester CJ
    Ann Clin Biochem; 2004 May; 41(Pt 3):213-9. PubMed ID: 15117435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial hypercholesterolemia: recognition and prevention of cardiac complications at a young age].
    Trip MD; Lansberg PJ; de Jongh S; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(30):1425-8. PubMed ID: 10932693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse cholestrol transport substantially influences the individual risk of coronary heart disease in hypercholesterolaemic patients.
    Poledne R; Rosolová H
    Eur Heart J; 2001 Mar; 22(6):442-3. PubMed ID: 11237535
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
    Geiss HC; Schwandt P; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
    Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S
    J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.